BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
Colorectal cancers (CRCs) remain the most prevalent malignancies worldwide [1] with incidences increasing approximately by 22% over the past 10 years among patients
Source: Radiotherapy and Oncology - Category: Radiology Authors: Yin-Chou Hsu, Chi-Wen Luo, Wei-Lun Huang, Chun-Chieh Wu, Chia-Lin Chou, Chih-I Chen, Shu-Jyuan Chang, Chee-Yin Chai, Hui-Ching Wang, Tzu-Yi Chen, Chien-Feng Li, Mei-Ren Pan Tags: Original Article Source Type: research
More News: Cancer | Cancer & Oncology | Chia | Colorectal Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Radiology | Rectal Cancers